Compare Carnival Corp (CCL) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Carnival Corp vs Zoetis Inc — how do they compare? Carnival Corp trades at $27.76 (market cap $37.98B), while Zoetis Inc trades at $72.53 (market cap $31.14B). The key difference: Carnival Corp is the larger of the two by market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| CCL | ZTS | |
|---|---|---|
Market Cap | $37.98B | $31.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $33.99 | $156.76 |
52-Week Low | $23.89 | $71.91 |
Enterprise Value | $61.91B | $38.70B |
Dividend Yield | 1.62% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Carnival Corporation (CCL) trades at $27.82, showing modest daily gains of 0.25%. The stock maintains strong fundamental momentum with consecutive earnings beats in recent quarters (Q4 2025 and Q1 2026) and improving profitability trends. Technical indicators show a bearish bias in moving averages while oscillators remain neutral. The company demonstrates robust operational recovery with revenue growth from $12.2B in 2022 to $26.6B in 2025, and positive net cash flow of $727M in 2025 after years of negative cash flow.
CCL presents a compelling recovery story with analyst consensus pointing to 26% upside to the $35.18 price target. Investment opportunities include sustained travel demand, fleet expansion, and debt reduction progress. Key risks involve fuel price volatility, competitive pressures, and execution of growth initiatives amid economic uncertainty. The stock's attractive valuation (P/E 12.49x) and 59.6% analyst buy rating support a positive medium-term outlook.
Zoetis (ZTS) trades at $72.42, down 3.27% amid bearish technical signals and recent earnings pressure. The stock shows strong fundamentals with 27.69% net margins and 64.91% ROE, but faces headwinds from softening pet healthcare demand. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a lowered 2026 outlook. Analyst consensus remains positive with a $94.90 price target despite near-term challenges.
The outlook remains cautiously optimistic given ZTS's dominant market position and profitability, though near-term performance depends on reversing companion animal segment weakness. Investment opportunity exists at current discounted valuation (P/E 12.29), balanced against competitive pressures and class action litigation risks. Upside potential aligns with analyst targets if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Carnival Corp
Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.
Read more on CCL →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
